Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Transplantation|March 8, 2011
Coronary artery disease from isolated non-H2-determined incompatibilities in transplanted mouse heartsPaul S Russell, Catharine M Chase, Joren C Madsen, et al.Plos One|October 5, 2023
Functional analysis of Collagen 17a1: A genetic modifier of junctional epidermolysis bullosa in miceThomas J Sproule, Robert Y Wilpan, Benjamin E Low, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2011
MHC class I family proteins retard systemic lupus erythematosus autoimmunity and B cell lymphomagenesisCaroline G McPhee, Thomas J Sproule, Dong-Mi Shin, et al.International Immunology|November 2, 2006
Enhanced half-life of genetically engineered human IgG1 antibodies in a humanized FcRn mouse model: potential application in humorally mediated autoimmune diseaseStefka B Petkova, Shreeram Akilesh, Thomas J Sproule, et al.Disease Models & Mechanisms|June 3, 2020
Diverse dystonin gene mutations cause distinct patterns of Dst isoform deficiency and phenotypic heterogeneity in Dystonia musculorum miceNozomu Yoshioka, Yudai Kabata, Momona Kuriyama, et al.Journal of Immunology (Baltimore, Md. : 1950)|October 1, 2013
IL-21 is a double-edged sword in the systemic lupus erythematosus-like disease of BXSB.Yaa miceCaroline G McPhee, Jason A Bubier, Thomas J Sproule, et al.Nature Biotechnology|January 19, 2010
Enhanced antibody half-life improves in vivo activityJonathan Zalevsky, Aaron K Chamberlain, Holly M Horton, et al.Plos One|October 26, 2023
Dystonin modifiers of junctional epidermolysis bullosa and models of epidermolysis bullosa simplex without dystonia musculorumThomas J Sproule, Robert Y Wilpan, John J Wilson, et al.Plos Genetics|February 20, 2014
Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in miceThomas J Sproule, Jason A Bubier, Fiorella C Grandi, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2003
The MHC class I-like IgG receptor controls perinatal IgG transport, IgG homeostasis, and fate of IgG-Fc-coupled drugsDerry C Roopenian, Gregory J Christianson, Thomas J Sproule, et al.Pageof 4